Researchers say benefits of two-dose Shingrix vaccine could be comparable to taking daily blood pressure medication

The current shingles vaccine appears to significantly lower the risk of heart attack and stroke, according to scientists who say it could help prevent thousands of deaths each year.

The research, based on records of 70,000 people in the US, found that those who had received Shingrix had a 12% lower risk of a cardiovascular diagnosis in the following three and a half years. If confirmed, this benefit would be comparable to taking a daily blood pressure-lowering medication, the scientists said.

A growing body of evidence suggests the vaccine may also lower risk of stroke and heart attack

One in three people in the US get shingles. Despite this, US vaccination rates remain low – about 35% of adults over 60, consistent with overall vaccination trends.

“We have a vaccine that works really well,” says Dr Andrew Wallach, ambulatory care chief medical officer at NYC Health + Hospitals. “But there is a lot of what I call vaccine fatigue right now.”